Updated immunisation reference page: Mpox

Mpox (monkeypox) is a viral zoonosis (an infection spread from animals to humans) caused by a virus that belongs to the Orthopoxvirus genus (which also causes the variola virus responsible for smallpox disease and the vaccinia virus, which is used in smallpox vaccines). Since the eradication of smallpox in 1980, mpox has become the most important orthopoxvirus affecting humans, however, causes less severe disease than smallpox.

Increasing numbers of Mpox have been reported globally over the last 2 years, with 141 confirmed or probable cases identified in Australia as of November 2022. Vaccination is currently recommended for individuals identified at highest risk of exposure and severe disease.

Our immunisation reference page has recently been updated to include:

  • intradermal administration recommendations
  • changes in terminology for pre-exposure and post-exposure prophylaxis.

To view the updated page in full, refer to the link below:

MVEC: Mpox (monkeypox)


Updated Myocarditis, pericarditis and COVID-19 vaccines animation

MVEC’s Myocarditis, pericarditis and COVID-19 vaccines animation has been updated following the most recent changes to the guidance on myocarditis and pericarditis associated with COVID-19 vaccination.   

This update reflects ATAGI’s recent advice which has identified that all of the COVID-19 vaccines available within Australia (including non-mRNA COVID-19 vaccines) carry a small increased risk of myocarditis or pericarditis occurring following vaccination.  

To view the updated animation, follow the link below to our reference page:  

MVEC: Myocarditis and pericarditis following COVID-19 vaccines    


MVEC holiday period closure

On behalf of the MVEC Team, we wish you a very happy and safe holiday season with your loved ones.  

Our team will be taking a break and will return in February to provide you with more vaccine education, resources and events in 2023. We'd love to hear from you if there are any specific vaccine topics you would like to see covered next year! 

We also want to say a huge thank you to all our amazing collaborators who have kindly shared their expert knowledge across a number of important vaccine topics and across all of the MVEC platforms this year! 

If you’re travelling this holiday season, stay safe, make sure your vaccines are up to date and pack your sunscreen and insect repellent! 


Updated immunisation reference page: Vaccine administration

Most vaccines available for use in Australia are administered via intramuscular or subcutaneous route, with several being administered intradermally or orally. Administering vaccines via the recommended route and using correct technique is of paramount importance to ensure optimal immune response, minimise side effects and reduce the risk of injury to the patient. 

Our Administration of injected vaccines – correct technique reference page has recently been updated and renamed Vaccine administration to include information on injectable and oral routes of vaccine administration. The Vaccine administration page also incorporates information previously found on the Intradermal immunisation reference page. 

To view the updated page in full, follow the link below:   

MVEC: Vaccine administration  


Updated immunisation reference page: Measles

Measles is a highly contagious illness caused by the measles virus of the Morbillivirus family. 

Infection is characterised by 3-4 days of fever, malaise, cough, coryza and conjunctivitis. A maculopapular rash then develops lasting up to 7 days. Complications of measles infections can include pneumonia, otitis media and encephalitis, which carries a mortality rate of 10-15%.  

Sub-acute sclerosing panencephalitis (SSPE) is a rare progressive neurological disorder that can develop 2-10 years after an initial measles infection and is fatal in all cases. 

Our measles reference page has recently been updated to include information on measles prevention, precautions and contraindications to vaccination and post-exposure prophylaxis. 

To view the updated page, refer to the link below: 

MVEC: Measles 


National Cervical Cancer Awareness Week 2022

Almost all cervical cancers are caused by the human papillomavirus, or HPV. Most HPV infections are preventable through vaccination, with the HPV vaccine preventing 93% of cervical cancers.

National Cervical Cancer Awareness Week is taking place from 7 – 13 November and provides a strong platform to raise continued awareness of cervical cancer and unite Australians to take action to help Australia make cervical cancer history.

HPV vaccines are fully funded for all students in year 7 (or age-equivalent) through the high school immunisation program; however, any missed doses can be obtained at your GP, pharmacy or local council.

For more information visit our Human papillomavirus (HPV) immunisation reference page.


Updated immunisation reference page: Monkeypox (MPX)

Monkeypox is a viral zoonosis (an infection spread from animals to humans). It is caused by a virus that belongs to the Orthopoxvirus genus (which also causes the variola virus responsible for smallpox disease and the vaccinia virus, which is used in smallpox vaccines). 

Historically, smallpox vaccines have been used in the prevention of smallpox infection, however, they are also likely to be effective against monkeypox. 

There are two types of smallpox vaccines available for use in Australia for the prevention of monkeypox: 

  • ACAM2000™ – 2nd generation, live-attenuated vaccine 
  • JYNNEOS® – 3rd generation, non-replicating vaccine 

Our Monkeypox reference page has been updated to included expanded eligibility criteria for those at highest risk of being infected.  

To view the updated page in full, follow the link below: 

MVEC: Monkeypox


Updated immunisation reference page: Japanese encephalitis

Japanese encephalitis virus (JEV) is a rare but potentially serious infection caused by the flavivirus and is spread to humans through mosquito bites. It is a leading cause of vaccine-preventable encephalitis (brain infection) in Asia and the Western Pacific. It has recently been detected in piggeries in Victoria and the Eastern states of Australia and human cases have been reported. 

Our Japanese encephalitis reference page has been updated to include expanded eligibility criteria for Victorians in flood affected areas in Northern Victoria where more mosquitoes are present.  

To view the updated page in full, follow the link below: 

MVEC: Japanese encephalitis 


Updated Immunisation reference page: Mandatory vaccine directions in Victoria

A vaccine mandate means that proof of vaccination, or an authorised medical exemption, is required in certain settings. Mandating is generally considered a late step in optimising vaccine uptake, as it is important to ensure vaccine access is available in an equitable way, before progressing to a mandate. Vaccine mandates may vary depending on the jurisdiction and there may be some variations around Australia.    

Our mandatory vaccine directions reference page has recently been updated to include the directions relevant to individuals in Victoria. They include: 

  • vaccine specific directions  
  • policy specific directions. 

To view the updated page in full, follow the link below:  

MVEC: Mandatory vaccine directions in Victoria 


Updated Immunisation reference page: Epilepsy and immunisation page

Epilepsy is a disorder of the brain that leads to a person having seizures. Whilst the cause of epilepsy in most people is often unknown, it can include genetic conditions, brain injury or infection, hypoxic insult at birth, brain tumours or neurodegenerative diseases.   

Infections, including those that are vaccine preventable (eg. measles, influenza, COVID-19 etc) can trigger seizures in people with epilepsy. Whilst vaccination is generally recommended, in rare instances a vaccine can also cause a seizure. This is why a risk/benefit assessment is important when planning vaccination for people with epilepsy.  

Our reference page has recently been updated to detail:    

  • epilepsy and vaccine-proximate seizures 
  • management of immunisation in populations with genetic epilepsies prone to vaccine-proximate seizures (Dravet syndrome and GEFS+)
  • immunisation recommendations and management. 

To view the page in full, follow the link below:  

MVEC: Epilepsy and immunisation page